website templates free download

Antibody-Dependent Cellular Phagocytosis (ADCP) 

There’s a BIOENSIS solution for each of your predictive pharmacology challenges

BIOENSIS 3D Antibody-Dependant Cellular Phagocytosis (ADCP) allows for better decision-making earlier in the drug development process. Our unique antibody-dependent cellular phagocytosis (ADCP) platforms enable efficacy evaluation of your therapeutic antibodies.

Key assay features:

• Over 150 target tumor cell lines available for testing
• Effector cells: human monocyte-derived macrophages
• Models tested high-throughput format
• Precision EC50 results
• Flexible testing protocols including single and combination agents

Please contact us to discuss your study and an up to date list of available cell lines   

Don’t see it here? BIOENSIS has the expertise and flexibility to develop custom assays designed to answer your critical pharmacology questions.

Quick Inquiry


19201 120TH AV NE, Suite 107
Bothell, WA 98011


Phone: 425-246-6040